BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Pioglitazone (Actos®, Competact®, Tandemact®): Guide for prescription and risk management

Active substance: pioglitazone

The company Takeda Pharma has published the "Pioglitazone Prescriber's Guide: Patient Selection and Risk Minimisation" thus implementing a further risk minimisation measure from the corresponding decision of the EU Commission.

risk information - full text (available in German only)